Embryonic Neural Precursor Cell Scholarly Journal
RG
cells appear through differentiation of precursor
cells referred to as “neuroepithelial cells” that originally form the walls of the ectoderm . Neuroepithelial precursor
cells arise from the ectoderm early in development and are recognizable by their radial alignment and bipolar morphology—one process of the cell contacts the lumen of the ventricle, and therefore the second process usually contacts the pial meninges. Neuroepithelial
cells have the potential to undergo self-renewing symmetric divisions that increase the dimensions of the precursor cell pool in early stages of development while forming the neural plate. After closure of the ectoderm , neuroepithelial
cells begin to upregulate glial specific factors, at which point they're thought to rework into RG
cells and acquire the potential to get
neurons and glia (Aaku-Saraste et al., 1996; Morest and Silver, 2003). This cellular transformation is clear at the morphological level by the lengthening of the cellular process that contacts the pial meninges, which we ask as “pial fiber,” and which is additionally mentioned as “basal process.” RG
cells located within the VZ are now considered to be the first NPC in many regions of the developing brain. Within the dorsal forebrain primary RG
cells within the VZ are often identified by expression of the nuclear transcription factor Pax6 and lack of expression for extra transcription factors like Tbr2 G
cells are shown to exhibit several patterns of division and generate multiple cell types in vitro and in vivo during cortical histogenesis.
High Impact List of Articles
-
The laparoscopic solution in a case of congenital cystic duct anomaly: a case report and review of the literature
Kiril G. Kirov
Case Report: Clinical Investigation
-
The laparoscopic solution in a case of congenital cystic duct anomaly: a case report and review of the literature
Kiril G. Kirov
Case Report: Clinical Investigation
-
The laparoscopic solution in a case of congenital cystic duct anomaly: a case report and review of the literature
Kiril G. Kirov
Case Report: Clinical Investigation
-
The laparoscopic solution in a case of congenital cystic duct anomaly: a case report and review of the literature
Kiril G. Kirov
Case Report: Clinical Investigation
-
The laparoscopic solution in a case of congenital cystic duct anomaly: a case report and review of the literature
Kiril G. Kirov
Case Report: Clinical Investigation
-
The laparoscopic solution in a case of congenital cystic duct anomaly: a case report and review of the literature
Kiril G. Kirov
Case Report: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Trinh Le Huy and Bui My Hanh
Research Article: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
Relevant Topics in Clinical